Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
Official abstract: The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for Chimeric VLP Vaccines to Prevent HTLV-1 Infection.